Emelia Ansu Gyeabourh
About Emelia Ansu Gyeabourh
Emelia Ansu Gyeabourh is a Scientist in Analytical Development at Sana Biotechnology, Inc., where she has worked since 2021. She specializes in optimizing assays for viral vector characterization and has extensive experience in analytical methods and regulatory reporting.
Work at Sana Biotechnology
Emelia Ansu Gyeabourh has been employed at Sana Biotechnology, Inc. since 2021 as a Scientist in Analytical Development. Based in Cambridge, Massachusetts, she has focused on optimizing quantitative Polymerase Chain Reaction (qPCR) and Enzyme-Linked Immunosorbent Assay (ELISA) for the characterization of viral vectors. Her role includes streamlining assays for media screening and conducting reviews and approvals of Standard Operating Procedures (SOPs), Intellectual Property (IP) forms, and technical reports. She also trains Research Scientists on various assays and participates in project meetings, delivering presentations on her findings.
Previous Experience
Before joining Sana Biotechnology, Gyeabourh accumulated extensive experience in the biotechnology and pharmaceutical sectors. She worked at MassBiologics for 14 years in various roles, including Research & Development Associate I, II, and III. During this time, she served as the Principal Lead for the Lyme project, overseeing project assignments and ensuring successful completion. She also held positions at Unilever as a Laboratory Analyst and AstraZeneca as an Intern. Additionally, she worked as a Pharmacy Technician at CVS Pharmacy for two years.
Education and Expertise
Gyeabourh holds a Master's degree in Chemistry from the University of Liverpool. She also completed a Graduate Course in Immunology at UMass Boston. Her educational background supports her expertise in analytical development, where she has developed methods for various analytical techniques, including UPLC, HPLC, CE, ELISAs, and cell-based assays. Her training and experience enable her to conduct stability testing on formulation screening and characterization of drug substances and products.
Research Contributions
In her current role, Gyeabourh has authored numerous analytical reports for regulatory filings, including reference standard reports, Certificates of Testing (COTs), and stability reports. She has successfully transferred all assays to Quality Control and co-qualified them, completing the necessary processes for project advancement. Her contributions also include conducting stability testing for Contract Manufacturing Organization (CMO) projects and other biologics, showcasing her commitment to advancing scientific research and development.
Professional Development
Gyeabourh has engaged in various professional development activities throughout her career. As a Visiting Scholar at The Ohio State University in 2019, she gained additional insights into research methodologies. She actively participates in project meetings and conducts presentations, enhancing her communication skills and contributing to collaborative efforts within her teams. Her ongoing training of Research Scientists reflects her commitment to knowledge sharing and professional growth in the scientific community.